Evidence map›Paper›PMID 33195616›Full record

ArticleFrontiers in veterinary science2020

The Impact of BKI-1294 Therapy in Mice Infected With the Apicomplexan Parasite

Pablo Winzer, Dennis Imhof, Nicoleta Anghel, Dominic Ritler, Joachim Müller, Ghalia Boubaker, Adriana Aguado-Martinez, Luis-Miguel Ortega-Mora, Kayode K Ojo, Wesley C VanVoorhis and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in veterinary science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Microorganisms · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Pablo WinzerInstitute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Dennis ImhofInstitute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Nicoleta AnghelInstitute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Dominic RitlerInstitute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Joachim MüllerInstitute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Ghalia BoubakerInstitute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Adriana Aguado-MartinezInstitute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Luis-Miguel Ortega-MoraSaluvet, Animal Health Department, Faculty of Veterinary Sciences, Complutense University of Madrid, Ciudad Universitaria s/n, Madrid, Spain.
Kayode K OjoCenter for Emerging and Re-emerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, United States.
Wesley C VanVoorhisCenter for Emerging and Re-emerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, United States.
Andrew HemphillInstitute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
University of Bern · CHUniversity of Washington · USUniversidad Complutense de Madrid · ES

Funding

Bumped Kinase Inhibitors: Novel Therapeutics for Cryptosporidiosis&ToxoplasmosisR01AI111341 · NIAID · UNIVERSITY OF WASHINGTON · PI VAN VOORHIS, WESLEY C · 2014 to 2018
$6.4M
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvumR01AI089441 · NIAID · UNIVERSITY OF WASHINGTON · PI MERRITT, ETHAN A, PARSONS, MARILYN · 2010 to 2014
$5.0M
Dual Use Therapeutics for Cryptosporidiosis, Toxoplasmosis, and NeosporosisR01HD080670 · NICHD · UNIVERSITY OF WASHINGTON · PI VAN VOORHIS, WESLEY C · 2014 to 2018
$1.9M
NIAID NIH HHS R01 AI089441NIAID NIH HHS R01 AI111341NICHD NIH HHS R01 HD080670
6 · The paper itself

Abstract

Exposure of

Indexed as

bumped kinase inhibitorcalcium-dependent protein kinaseimmune responselive-vaccinemouse modelneosporosisproteomicsreal time PCR

Identifiers

PMID33195616
PMCPMC7593410
OpenAlexW3092870563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.